Atossa Therapeutics, Inc. · NASDAQ:ATOS

Galli Stephen J received 10,000 Atossa Therapeutics, Inc. shares as an award (Form 4)

Traded May 12, 2026 · Filed May 14, 2026

On May 12, 2026, Galli Stephen J (Director) received 10,000 Atossa Therapeutics, Inc. shares as an award, leaving 10,006 shares. Filed May 14, 2026 (Form 4).

Awarded
10,000 shares
Holding after
10,006 shares
Trading plan
No
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 12, 2026Common StockAward10,00010,006Direct

Source

View original at SEC

Related